Bellevue Group AG - Jun 1, 2025 SCHEDULE 13G Report for Agios Pharmaceuticals, Inc. Common Stock (AGIO)

Filing Manager
Bellevue Group AG
Reporting Manager
Bellevue Group AG
Security
Agios Pharmaceuticals, Inc. Common Stock
Symbol
AGIO
Shares outstanding
57.6M shares
Disclosed Ownership
3.52M shares
Ownership
6.1%
Form type
SCHEDULE 13G
Date filed
7/7/2025, 07:32 PM
Date of event
Jun 1, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bellevue Group AG 6.1% 3.52M 0 3.52M /s/ Stefano Montalbano Stefano Montalbano/ Chief Financial Officer
Bellevue Asset Management AG 6.1% 3.52M 0 3.52M /s/ Christoph Eisenring Christoph Eisenring/ Head Legal & Compliance